Analytical Method Change for Neuravastatin. Specification Change for Neuravastatin — critical change. Impacts 6 markets and 2 variations.

Change Number
CHG-2022-0187
Type
Analytical Method Change
Status
Blocked
Owner
Carlos Mendez
Initiated
2022-06-06
Description

Specification Change for Neuravastatin — critical change

Impacted Markets (6)
CA — CanadaCH — SwitzerlandIT — ItalyTW — TaiwanRU — RussiaAT — Austria
Impacted Modules
3.2.S2.3.P3.2.P4.2.1
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved